InsidersTradesSigma
Track the 昊海生科 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 昊海生科 has recorded 8 public disclosures. Market capitalisation: €6.9bn. The latest transaction was disclosed on 29 June 2026 (Sale). Among the most active insiders: 甘人宝. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€9,949
1 ops.
Buy Volume
€3m
7 ops.
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,630 of 29,063 companies
58.3
score / 100
Value52
Quality65
FCF yld4.5%
Earn yld3.7%
EV/EBITDA15.5x
ROE2.1%
Gross mgn70%
Net mgn10%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations8 total
8 of 8 declarations
关于 昊海生科
昊海生科是一家在XSHG市场上市的健康和制药领域的公司。它专注于创新医药产品的开发和生产。